These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29216618)

  • 1. Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3).
    Bakhteyar H; Cassone C; Kohan HG; Sani SN
    Int J Pharm Compd; 2017; 21(5):418-425. PubMed ID: 29216618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of extemporaneously compounded slow-release capsules containing morphine sulfate or oxycodone hydrochloride.
    Glowiak DL; Green JL; Bowman BJ
    Int J Pharm Compd; 2005; 9(2):157-64. PubMed ID: 23924916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compounding of slow-release niacinamide capsules: feasibility and characterization.
    Radojkovic B; Milić J; Calija B
    Int J Pharm Compd; 2012; 16(5):434-7. PubMed ID: 23072204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
    Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
    Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices.
    Bravo SA; Lamas MC; Salamón CJ
    J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of morphine sulfate from compounded slow-release capsules: the effect of formulation on release.
    Bogner RH; Szweijkowski J; Houston A
    Int J Pharm Compd; 2001; 5(5):401-5. PubMed ID: 23981979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug release kinetic analysis and prediction of release data via polymer molecular weight in sustained release diltiazem matrices.
    Adibkia K; Ghanbarzadeh S; Mohammadi G; Khiavi HZ; Sabzevari A; Barzegar-Jalali M
    Drug Res (Stuttg); 2014 Mar; 64(3):118-23. PubMed ID: 23986307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation development and in vitro evaluation of theophylline microcapsules.
    Ahmad M; Akhtar N; Murtaza G; Hussain SW
    Pak J Pharm Sci; 2012 Jan; 25(1):15-9. PubMed ID: 22186304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study.
    M K; Sistla R; Shastri NR
    Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of metoprolol tartrate extended-release matrix tablet formulations for regulatory policy consideration.
    Nellore RV; Rekhi GS; Hussain AS; Tillman LG; Augsburger LL
    J Control Release; 1998 Jan; 50(1-3):247-56. PubMed ID: 9685891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of formulation factors on tablet formulations with liquid permeation enhancer using factorial design.
    Bejugam NK; Parish HJ; Shankar GN
    AAPS PharmSciTech; 2009; 10(4):1437-43. PubMed ID: 19957114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of mixture experimental design in the formulation and optimization of matrix tablets containing carbomer and hydroxy-propylmethylcellulose.
    Petrovic A; Cvetkovic N; Ibric S; Trajkovic S; Djuric Z; Popadic D; Popovic R
    Arch Pharm Res; 2009 Dec; 32(12):1767-74. PubMed ID: 20162406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once daily controlled release matrix tablet of Prochlorperazine maleate: influence of Ethocel® and/or Methocel® on in vitro drug release and bioavailability.
    Badshah A; Subhan F; Shah NH; Bukhari NI; Saeed M; Shah KU
    Drug Dev Ind Pharm; 2012 Feb; 38(2):190-9. PubMed ID: 21749268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.
    Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
    Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
    Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of controlled-release matrix tablet of risperidone: influence of Methocel®- and Ethocel®-based novel polymeric blend on in vitro drug release and bioavailability.
    Badshah A; Subhan F; Rauf K; Bukhari NI; Shah K; Khan S; Ahmed Z; Khan I
    AAPS PharmSciTech; 2011 Jun; 12(2):525-33. PubMed ID: 21494924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.